Management of Incidental Pulmonary Artery Filling Defect

Initial Diagnostic Confirmation

The European Society of Cardiology recommends requesting radiologist review or second opinion for incidental pulmonary artery filling defects because single subsegmental filling defects have high false-positive rates on modern CT pulmonary angiography (CTPA), and misdiagnosis leads to unnecessary anticoagulation with bleeding risk 1
Technical artifacts that mimic PE include transient interruption of contrast from deep inspiration, flow artifacts from Valsalva maneuver during breath-hold, and mixing artifacts in patients on extracorporeal membrane oxygenation, as noted by the European Heart Journal 2
True PE characteristics on imaging include filling defect visible on multiple consecutive slices and multiple planes, distinct borders, "rim sign" or "railway track sign," and acute angles with vessel wall if eccentric, according to the European Heart Journal 2

The American College of Chest Physicians recommends performing bilateral lower extremity venous ultrasound to exclude proximal DVT in patients with isolated subsegmental PE, as the presence of DVT mandates anticoagulation 3
For patients with low recurrence risk, clinical surveillance is preferred over anticoagulation, whereas for those with high recurrence risk, anticoagulation is preferred over surveillance, as suggested by the American College of Chest Physicians 3

The European Society of Cardiology recommends treating incidental asymptomatic PE involving segmental or more proximal vessels identically to symptomatic PE with anticoagulation, as observational data shows similar prognosis between asymptomatic and symptomatic PE 3
The European Heart Journal suggests initiating anticoagulation immediately while diagnostic workup proceeds, unless active bleeding or absolute contraindications exist, and preferring direct oral anticoagulants (DOACs/NOACs) over traditional low-molecular-weight heparin bridged to warfarin unless contraindications exist 1
Right ventricular assessment via echocardiography or CT is recommended to stratify risk and determine need for monitoring versus early discharge, according to the European Heart Journal 1

The European Society of Cardiology recommends a minimum of 6-12 months of anticoagulation for first episode unprovoked/idiopathic PE, with reassessment at 3-6 months for extended therapy 1
For patients with active cancer, extended anticoagulation with low-molecular-weight heparin or DOAC is recommended per cancer-associated thrombosis guidelines, as suggested by the American College of Chest Physicians 3

The European Society of Cardiology warns against assuming all filling defects are PE, particularly for isolated subsegmental defects, and emphasizes the importance of radiologist confirmation 1
The American College of Chest Physicians advises against anticoagulating without excluding proximal DVT first when considering surveillance for ISSPE, as DVT presence changes management 3
Unnecessary anticoagulation can cause major bleeding in 1-3% of patients annually, highlighting the importance of careful diagnosis and treatment, as noted by the European Heart Journal 1

Immediate review of CT pulmonary angiography (CTPA) is required to differentiate true pulmonary embolism (PE) from artifacts, followed by risk stratification and prompt anticoagulation when PE is confirmed. 4
True PE on CTPA is characterized by distinct, sharp borders of the filling defect that are surrounded by contrast material. 4
Specific CT signs that support a true embolus include the “rim sign” (contrast encircling a central defect) and the “railway‑track sign” (parallel lines of contrast flanking the defect). 4

Transient interruption of contrast caused by deep inspiration can create pseudo‑defects. 4
Flow artifacts produced by a Valsalva maneuver during breath‑hold may result in poor pulmonary artery enhancement. 4
Streak artifacts arise from high‑concentration contrast in the superior vena cava, potentially simulating emboli. 5
Breathing‑motion artifacts generate pseudo‑hypoattenuating areas that can be mistaken for thrombus. 5

Instruct patients to perform a shallow breath‑hold (avoid deep inspiration) to reduce motion‑related artifacts. 4
Use low‑concentration contrast (120–200 mg iodine/ml) delivered at a high flow rate (4–5 ml/s) to minimize streak artifacts in the right pulmonary artery. 5
When a central venous catheter is present, shorten the scan delay to approximately 5 seconds to improve arterial opacification. 5

Assessment of right‑ventricular (RV) function by echocardiography or CT is essential to classify PE severity and to decide between intensive monitoring or early discharge. 6
A distended inferior vena cava with reduced inspiratory collapsibility is an imaging marker of RV dysfunction. 4

Pulmonary artery sarcoma typically appears as an eccentric mass that is contiguous with the vessel wall and causes irregular vessel dilation, distinguishing it from thrombotic emboli. 5

Systematic review of cine‑mode images and multiplanar reformations helps differentiate true embolic defects from flow‑related artifacts. 5
Recognize that RV assessment directly influences prognosis and determines the intensity of patient monitoring. 6